logo

For the Inventor, By the Inventor

Menlo Park, CA, United States of America

Daria D Mochly-Rosen

This inventor holds 59 USPTO granted patents and 10 published patent applications, primarily in Mitochondrial Regulation (CPC class A61K). Top assignees: Leland Stanford Junior University, Johns Hopkins University, The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 1996-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Daria D Mochly-Rosen. Retrieved from https://idiyas.com/inventor/daria-d-mochly-rosen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 59 

% Patents Active = 37.3

Average Co-Inventor Count = 1.9

ph-index = 9

Forward Citations = 374(Granted Patents)

Forward Citations (Not Self Cited) = 224(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Melo Park, CA (US) (2010)
  • Palo Alto, CA (US) (2014)
  • Menlo Park, CA (US) (1996 - 2024)

Company Filing History:

goldMedal57 out of 5,519 
 
Leland Stanford Junior University
 patents
silverMedal2 out of 3,806 
 
Johns Hopkins University
 patents
bronzeMedal2 out of 3,699 
 
The United States of America, as Represented by the Secretary, Department of Health and Human Services
 patents
4. 1 out of 810 
 
Indiana University
 patents
5. 1 out of 37 
 
Terrapin Technologies, Inc.
 patents
6. 1 out of 2 
 
The United States of America as Represented by Nih Division of Extramural Inventions and Technology Resources (Deitr)
 patents
7. 1 out of 1,384 
 
Washington University
 patents
where one patent can have more than one assignee

Years Active: 1996-2024

Loading Chart...
Areas of Expertise:
Mitochondrial Fission
Peptide Modulators
Stem Cell Proliferation
Aldehyde Dehydrogenase
Protein Kinase C
Ischemic Injury
Pain Treatment
Cerebral Blood Flow
Nano-Scale Devices
Endometriosis
Hypertension-Induced Heart Failure
Tissue Damage Protection
59 patents (USPTO):Explore Patents
1. 11974981 - Methods and compositions for treating endometriosis and endometriosis associated symptoms (2024-05-07),
2. 11136362 - Peptide modulators of specific calcineurin protein-protein interactions (2021-10-05),
3. 10912815 - Inhibitors of mitochondrial fission and methods of use thereof (2021-02-09),
4. 10578610 - Peptide regulators of mitochondrial fusion and methods of use (2020-03-03),
5. 10457659 - Compositions and methods for increasing proliferation of adult salivary stem cells (2019-10-29),
6. 10245297 - Inhibitors of mitochondrial fission and methods of use thereof (2019-04-02),
7. 10227304 - Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof (2019-03-12),
8. 10131691 - Compositions and methods for specific regulation of pyruvate dehydrogenase kinase (2018-11-20),
9. 9737486 - Method and use of nano-scale devices for reduction of tissue injury in ischemic and reperfusion injury (2017-08-22),
10. 9730977 - Inhibitors of mitochondrial fission and methods of use thereof (2017-08-15),
11. 9670162 - Mitochondrial aldehyde dehyrogenase-2 modulators and methods of use thereof (2017-06-06),
12. 9545393 - Methods and compositions for treating pain (2017-01-17),
13. 9370506 - Modulators of aldehyde dehydrogenase and methods of use thereof (2016-06-21),
14. 9365837 - Peptide inhibitors of protein kinase C (2016-06-14),
15. 9345693 - Modulators of aldehyde dehydrogenase activity and methods of use thereof (2016-05-24),

Title: The Innovative Journey of Daria D Mochly-Rosen: Pioneering Treatments and Peptide Modulators

Introduction:

Daria D Mochly-Rosen is a visionary inventor who has made significant contributions to the field of biotechnology and pharmaceuticals. Her relentless pursuit of novel treatments has led to the development of groundbreaking solutions for various medical conditions. Let's delve into her latest patents, career highlights, and collaborations that have shaped her remarkable journey in the world of innovations.

Latest Patents:

With an impressive portfolio of 59 patents, Daria D Mochly-Rosen continues to push the boundaries of medical science. One of her recent patents includes methods and compositions for treating endometriosis and its associated symptoms by administering an agent that promotes ALDH activity. Another patent focuses on peptide modulators of specific calcineurin protein-protein interactions, offering new avenues for treating conditions by selectively modulating these interactions.

Career Highlights:

Daria D Mochly-Rosen has made significant strides in her career, with her work being recognized and valued by prestigious institutions. She has been associated with the Leland Stanford Junior University, where her innovative research has paved the way for transformative medical solutions. Her dedication to advancing medical science is evident in the numerous patents she holds, reflecting her commitment to making a positive impact on healthcare.

Collaborations:

In the pursuit of cutting-edge innovation, Daria D Mochly-Rosen has collaborated with esteemed colleagues such as Che-Hong Chen and Wenjin Yang. These collaborations have been instrumental in expanding the scope of her research and bringing diverse perspectives to her work. By working alongside talented individuals, she has been able to achieve synergies that have led to the development of pioneering treatments and solutions.

Conclusion:

In conclusion, Daria D Mochly-Rosen stands as a trailblazing inventor whose ingenuity and passion have revolutionized the medical field. Her latest patents exemplify her commitment to addressing unmet medical needs and improving patient outcomes. Through her career highlights and collaborations, she continues to inspire the next generation of innovators to push boundaries, challenge the status quo, and make a lasting impact on the world of inventions and innovations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…